Clinical Trials Directory

Trials / Unknown

UnknownNCT06021262

Assessment of Nerve Damage Biomarkers in Acute and Chronic Organophosphate Toxicity

Assessment of the Prognostic Value of Nerve Damage Biomarkers in Acute and Chronic Organophosphate Toxicity

Status
Unknown
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Alexandria University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this observational study is to answer the following questions in individuals with acute and chronic exposure to organophosphates. The main questions to be addressed are 1. What are the prognostic values of neuroinflammatory markers? 2. What are the genotoxic effects of organophosphates? 3. what are the changes occurring in the levels of traditional oxidative stress and inflammatory markers?

Detailed description

This is a cross-sectional study that aims to assess the possible prognostic value of markers of neuroinflammation and nerve damage in patients with acute and chronic exposure to organophosphate pesticides by conducting a full proteomic and metabolomic profile. The possible genotoxic effect of common organophosphate pesticides will be studied as well. This will be conducted in parallel to the assessment of traditional markers of inflammation and oxidative stress. The target populations are patients with acute and chronic exposure to organophosphates with a total estimated number of 90 including individuals assigned to the control group with matched age and gender.

Conditions

Interventions

TypeNameDescription
OTHERexposure to organophosphatesorganophosphates are esters of phosphoric acids or Thio phosphoric acids that exist in pesticides, where patients can be chronically or acutely exposed to such compounds.

Timeline

Start date
2023-08-01
Primary completion
2023-12-01
Completion
2024-01-01
First posted
2023-09-01
Last updated
2023-09-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06021262. Inclusion in this directory is not an endorsement.

Assessment of Nerve Damage Biomarkers in Acute and Chronic Organophosphate Toxicity (NCT06021262) · Clinical Trials Directory